Goldman Sachs' CEO said the drawdown is likely to come in the next one to two years, while Morgan Stanley's boss said this ...

Concerns are mounting that the bullish stock market is due for a downturn, especially if AI stocks have been overvalued.

The bloodbath began at the Global Financial Leaders’ Investment Summit in Hong Kong. On stage, Goldman Sachs CEO David ...

Stocks were down sharply across the world, with major indexes in the U.S., Europe and Asia all lower as of Tuesday morning, after comments by corporate chief executives about high equity valuations ...

Live Updates Live Coverage Has Ended Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Vanguard S&P 500 ETF, market updates, ...

Guardant Health, Inc. ("Guardant Health") (Nasdaq: GH), a leading precision oncology company, today announced the ...

Analysts turn cautious on Gland Pharma as Goldman Sachs cuts target to Rs 1,700 and maintains a ‘Sell’ view, while Jefferies and Nomura stay neutral; near-term growth seen muted despite strong ...

Major stock indices showed signs of weakness amid growing concerns over high market valuations. The S&P 500 declined 0.7% as ...

Fiserv (FI) was trading lower as Morgan Stanley, BTIG, and Goldman Sachs cut their recommendation on the stock to ...

Live Updates Live Coverage Updates appear automatically as they are published. Updates will appear here as they are published ...

Sometimes, we see bubbles,” Burry said in a recent X post. “Sometimes, there is something to do about it. Sometimes, the only ...

With the S&P 500 (SPX) trading at an elevated forward price-to-earnings (P/E) ratio of 23x, investors have increasingly grown ...